Afficher la notice abrégée

dc.contributor.editorAkhtar, Juber
dc.contributor.editorAhmad, Mohammad
dc.contributor.editorIrfan Khan, Mohammad
dc.date.accessioned2023-02-15T14:53:16Z
dc.date.available2023-02-15T14:53:16Z
dc.date.issued2022
dc.identifierONIX_20230215_9781803560489_290
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/97251
dc.description.abstractDrug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and cosmeceuticals for topical use, ocular drug delivery systems, and drug development involving computer-aided drug design, machine learning, and artificial intelligence.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacologyen_US
dc.subject.otherOther branches of medicine
dc.titleDrug Development Life Cycle
dc.typebook
oapen.identifier.doi10.5772/intechopen.96842
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9781803560489
oapen.relation.isbn9781803560472
oapen.relation.isbn9781803560496
oapen.imprintIntechOpen
oapen.pages110


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/